AZD-0292

N/A

Report date: 2026/04/03 20:03:44

Base Information

Drug NameAZD-0292
Drug Alias NameAZD0292AZD-0292
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionType III secretion system protein modulators
TargetsType III secretion system protein
Therapy Area/IndicationsBronchiectasisPseudomonas Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[25] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca PlcAstrazeneca AbAstraZeneca global R & D (China) Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsBronchiectasisPseudomonas Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A